Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models

By sjmartinez • August 4, 2023

Li J, Xiao Y, Zhang Y, Li S, Zhao M, Xia T, Meng H. Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models. ACS Nano. 2023 Aug 3. doi: 10.1021/acsnano.2c10388. Epub ahead of print. PMID: 37535431.

Tags: inflammation resolution, Nano Medicine, nanomedicine, Publications, pulmonary drug delivery, Pulmonary fibrosis, specialized pro-resolving mediators

Correction: Reduction of pulmonary toxicity of metal oxide nanoparticles by phosphonate-based surface passivation

Cai X, Lee A, Ji Z, Huang C, Chang CH, Wang X, Liao YP, Xia T, Li R. Correction: Reduction of pulmonary toxicity of metal[...]

Role of ESCCAL-1 in regulating exocytosis of AuNPs in human esophageal squamous carcinoma cells

Gong F, Cui Y, Lv P, Liu J, Sun X, Han P, Zhou L, Xia T, Cao W. Role of ESCCAL-1 in regulating exocytosis of[...]

Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor

Luo L, Wang X, Liao YP, Xu X, Chang CH, Nel AE. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering[...]